2-[6-[(3S)-3-(cyclobutylamino)pyrrolidin-1-yl]pyridazin-3-yl]-4-fluoro-5-(5-methoxy-1,3,4-thiadiazol-2-yl)phenol
C21H23FN6O2S — CID 167503821
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-[(3S)-3-(cyclobutylamino)pyrrolidin-1-yl]pyridazin-3-yl]-4-fluoro-5-(5-methoxy-1,3,4-thiadiazol-2-yl)phenol
2-[6-[(3S)-3-(cyclobutylamino)pyrrolidin-1-yl]pyridazin-3-yl]-4-fluoro-5-(5-methoxy-1,3,4-thiadiazol-2-yl)phenol (PubChem CID 167503821) has the molecular formula C21H23FN6O2S and a molecular weight of 442.52 g/mol. Its IUPAC name is 2-[6-[(3S)-3-(cyclobutylamino)pyrrolidin-1-yl]pyridazin-3-yl]-4-fluoro-5-(5-methoxy-1,3,4-thiadiazol-2-yl)phenol.
Molecular Properties
| Compound Name | 2-[6-[(3S)-3-(cyclobutylamino)pyrrolidin-1-yl]pyridazin-3-yl]-4-fluoro-5-(5-methoxy-1,3,4-thiadiazol-2-yl)phenol |
|---|---|
| PubChem CID | 167503821 |
| Molecular Formula | C21H23FN6O2S |
| Molecular Weight | 442.52 g/mol |
| Exact Mass | 442.16 |
| IUPAC Name | 2-[6-[(3S)-3-(cyclobutylamino)pyrrolidin-1-yl]pyridazin-3-yl]-4-fluoro-5-(5-methoxy-1,3,4-thiadiazol-2-yl)phenol |
| SMILES | COc1nnc(-c2cc(O)c(-c3ccc(N4CC[C@H](NC5CCC5)C4)nn3)cc2F)s1 |
| InChI | InChI=1S/C21H23FN6O2S/c1-30-21-27-26-20(31-21)14-10-18(29)15(9-16(14)22)17-5-6-19(25-24-17)28-8-7-13(11-28)23-12-3-2-4-12/h5-6,9-10,12-13,23,29H,2-4,7-8,11H2,1H3/t13-/m0/s1 |
| InChIKey | KGEFJPIGYHTTAL-ZDUSSCGKSA-N |
| XLogP | 3.24 |
| TPSA | 96.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 442.52 |
| LogP ≤ 5 | 3.24 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167503821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.